P3 Health Partners Inc (NASDAQ:PIII) — Market Cap & Net Worth
Market Cap & Net Worth: P3 Health Partners Inc (PIII)
P3 Health Partners Inc (NASDAQ:PIII) has a market capitalization of $32.69 Million ($32.69 Million) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #23401 globally and #5039 in its home market, demonstrating a 5.59% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying P3 Health Partners Inc's stock price $9.83 by its total outstanding shares 3325858 (3.33 Million). See P3 Health Partners Inc capital spending ratio to understand how much of operating cash flow is reinvested back into capital assets.
P3 Health Partners Inc Market Cap History: 2021 to 2026
P3 Health Partners Inc's market capitalization history from 2021 to 2026. Data shows growth from $23.41 Million to $32.69 Million (0.29% CAGR).
Index Memberships
P3 Health Partners Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.46 Trillion | 0.00% | #668 of 976 |
|
NASDAQ Composite
IXIC
|
$40.26 Trillion | 0.00% | #2219 of 3165 |
Weight: P3 Health Partners Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
P3 Health Partners Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how P3 Health Partners Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
P3 Health Partners Inc's market cap is 0.01 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $6.12 Million | $1.05 Billion | -$270.13 Million | 0.01x | N/A |
| 2023 | $4.69 Million | $1.27 Billion | -$57.77 Million | 0.00x | N/A |
| 2024 | $747.99K | $1.50 Billion | -$135.85 Million | 0.00x | N/A |
| 2025 | $11.61 Million | $1.46 Billion | -$147.95 Million | 0.01x | N/A |
Competitor Companies of PIII by Market Capitalization
Companies near P3 Health Partners Inc in the global market cap rankings as of August 3, 2026.
Key companies related to P3 Health Partners Inc by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #327 globally with a market cap of $80.16 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #905 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #994 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1355 globally with a market cap of $18.52 Billion USD ( RM73.78 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #327 | HCA Healthcare, Inc. | NYSE:HCA | $80.16 Billion | $402.59 |
| #905 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €44.52 |
| #994 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1355 | IHH Healthcare Bhd | KLSE:5225 | $18.52 Billion | RM8.35 |
P3 Health Partners Inc Historical Marketcap From 2021 to 2026
Between 2021 and today, P3 Health Partners Inc's market cap moved from $23.41 Million to $ 32.69 Million, with a yearly change of 0.29%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $32.69 Million | +181.66% |
| 2025 | $11.61 Million | +1451.80% |
| 2024 | $747.99K | -84.05% |
| 2023 | $4.69 Million | -23.37% |
| 2022 | $6.12 Million | -73.86% |
| 2021 | $23.41 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of P3 Health Partners Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $32.69 Million USD |
| MoneyControl | $32.69 Million USD |
| MarketWatch | $32.69 Million USD |
| marketcap.company | $32.69 Million USD |
| Reuters | $32.69 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About P3 Health Partners Inc
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company was founded in 2020 and is based in Henderson, Nevada.